DK0707853T3 - Muselrelakserende farmaceutiske præparater - Google Patents
Muselrelakserende farmaceutiske præparaterInfo
- Publication number
- DK0707853T3 DK0707853T3 DK95115576.1T DK95115576T DK0707853T3 DK 0707853 T3 DK0707853 T3 DK 0707853T3 DK 95115576 T DK95115576 T DK 95115576T DK 0707853 T3 DK0707853 T3 DK 0707853T3
- Authority
- DK
- Denmark
- Prior art keywords
- pharmaceuticals
- tryptophan
- serine
- glycine
- muscle relaxing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI942166A IT1271031B (it) | 1994-10-21 | 1994-10-21 | Composizioni farmaceutiche miorilassanti |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0707853T3 true DK0707853T3 (da) | 1998-03-02 |
Family
ID=11369756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95115576.1T DK0707853T3 (da) | 1994-10-21 | 1995-10-02 | Muselrelakserende farmaceutiske præparater |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0707853B1 (da) |
AT (1) | ATE156016T1 (da) |
CA (1) | CA2160938C (da) |
DE (2) | DE69500490T2 (da) |
DK (1) | DK0707853T3 (da) |
ES (1) | ES2088379T3 (da) |
GR (2) | GR960300039T1 (da) |
HK (1) | HK1001719A1 (da) |
IT (1) | IT1271031B (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6911455B2 (en) | 1999-12-22 | 2005-06-28 | Smithkline Beecham Corporation | Methods for preparing pharmaceutical formulations |
WO2001045741A2 (en) * | 1999-12-22 | 2001-06-28 | Glaxo Group Limited | Methods for preparing pharmaceutical formulations |
DE102005030423A1 (de) * | 2005-06-30 | 2007-01-04 | Inresa Arzneimittel Gmbh | Neue Formulierung für Vecuroniumbromid |
BRPI0619565A2 (pt) * | 2005-12-08 | 2011-10-04 | Wyeth Corp | composições lipossÈmicas |
EP2712611A1 (en) | 2012-09-27 | 2014-04-02 | B. Braun Melsungen AG | Stabilized aqueous compositions of neuromuscular blocking agents |
RU2594062C2 (ru) * | 2013-07-23 | 2016-08-10 | Закрытое акционерное общество "ЭкоФармПлюс" | Способ получения фармацевтического состава рокурония бромида в форме стабильного лиофилизата и фармацевтический состав, полученный этим способом |
CN107638391B (zh) * | 2016-07-22 | 2020-10-16 | 海南合瑞制药股份有限公司 | 一种注射用苯磺顺阿曲库铵组合物 |
CN108676052B (zh) * | 2018-08-16 | 2020-05-22 | 北京市新里程医药科技有限公司 | 一种罗库溴铵的制备方法及其药物组合物 |
CN111374942B (zh) * | 2018-12-30 | 2022-09-13 | 鲁南制药集团股份有限公司 | 一种甾体类肌松药注射液及其制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0626850B1 (en) * | 1992-02-18 | 2002-05-15 | Pharmos Corporation | Dry compositions for preparing submicron emulsions |
GB9302455D0 (en) * | 1993-02-08 | 1993-03-24 | Lab Inpharm N V | Process for preparing a pharmaceutical preparation having neuromuscular blocking activity |
-
1994
- 1994-10-21 IT ITMI942166A patent/IT1271031B/it active IP Right Grant
-
1995
- 1995-10-02 DK DK95115576.1T patent/DK0707853T3/da active
- 1995-10-02 DE DE69500490T patent/DE69500490T2/de not_active Expired - Lifetime
- 1995-10-02 AT AT95115576T patent/ATE156016T1/de active
- 1995-10-02 EP EP95115576A patent/EP0707853B1/en not_active Expired - Lifetime
- 1995-10-02 DE DE0707853T patent/DE707853T1/de active Pending
- 1995-10-02 ES ES95115576T patent/ES2088379T3/es not_active Expired - Lifetime
- 1995-10-19 CA CA002160938A patent/CA2160938C/en not_active Expired - Fee Related
-
1996
- 1996-08-31 GR GR960300039T patent/GR960300039T1/el unknown
-
1997
- 1997-09-17 GR GR970402416T patent/GR3024761T3/el unknown
-
1998
- 1998-01-27 HK HK98100704A patent/HK1001719A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2160938C (en) | 2008-07-15 |
DE69500490T2 (de) | 1997-12-04 |
ITMI942166A0 (it) | 1994-10-21 |
DE69500490D1 (de) | 1997-09-04 |
HK1001719A1 (en) | 1998-07-03 |
GR3024761T3 (en) | 1997-12-31 |
ES2088379T3 (es) | 1997-10-16 |
ES2088379T1 (es) | 1996-08-16 |
CA2160938A1 (en) | 1996-04-22 |
EP0707853A1 (en) | 1996-04-24 |
DE707853T1 (de) | 1996-12-12 |
ITMI942166A1 (it) | 1996-04-21 |
EP0707853B1 (en) | 1997-07-30 |
ATE156016T1 (de) | 1997-08-15 |
GR960300039T1 (en) | 1996-08-31 |
IT1271031B (it) | 1997-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69614681D1 (de) | Pharmazeutische und/oder diätische zusammensetzungen mit antioxydationswirkung, welche carnosin und verzweigte aminosäure enthalten | |
PT792287E (pt) | Analogos peptidicos da proteina basica da mielina humana | |
IT1255258B (it) | Composizioni farmaceutiche per l'applicazione per via nasale. | |
ID21956A (id) | Asam n-(aril dan atau heteroarilasetil) amino ester, komposisi farmasi yang mengandungnya, dan metoda untuk menghambat pelepasan betha-amiloid peptida dan atau sintesanya dengan menggunakan senyawa tersebut | |
DE69604147D1 (de) | Flüssige zuzammensetzung zur stabilisierung von aminosäure-herbiziden | |
HK1039271A1 (en) | Method for prevention and/or cosmetic treatment ofskin stripe and use in dermatology. | |
NO965012L (no) | Farmasöytisk preparat som omfatter glukagon | |
TR199901132T2 (xx) | N-(aril/heteoaril) amino asit t�revleri, bunlar� i�eren farmas�tik bile�imler ve b�yle bile�ikler kullan�larak �-amiloid peptidinin sal�nmas�n� ve/veya sentezini inhibe etmek i�in y�ntemler. | |
ZA98214B (en) | Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1. | |
DK0707853T3 (da) | Muselrelakserende farmaceutiske præparater | |
EA200100354A1 (ru) | Фармацевтическая композиция, содержащая энтакапон или нитекапон, а также поперечно-сшитое производное целлюлозы | |
DE69533704D1 (de) | Bradykinin-antagonist peptide mit n-substituierten glycinen | |
ES2177024T3 (es) | Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer. | |
MX9300558A (es) | Nueva sulfonilurea, procedimiento para su preparacion y formulado farmaceutico que la contiene. | |
ATE201693T1 (de) | Hämoregulierende peptide | |
YU20050685A (sh) | Poboljšanje podnošljivosti farmaceutski delotvornih beta- amino kiselina | |
BG103632A (en) | Pharmaceutical compositions containing ibuprophene and domperidon for migraine treatment | |
ATE219763T1 (de) | Amid enthaltende kosmetische zusammensetzungen und neue amide | |
CA2218643A1 (en) | Oral pharmaceutical composition of piperidinoalkanol compounds in solution form | |
KR970073601A (ko) | 생리 활성 펩티드 함유 경비 투여용 조성물 | |
GEP20032975B (en) | Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition | |
FI942938A (fi) | Soijaproteiini tai -hydrolysaatit farmaseuttisissa koostumuksissa bioaktiivisten peptidien suojana entsymaattista inaktivoitumista vastaan | |
SE9901773D0 (sv) | Förebyggande av karies i tänderna | |
EA200100477A1 (ru) | Фармацевтическая композиция тнр и эналаприла | |
RU94028126A (ru) | Средство, обладающее иммуномодулирующей активностью |